GLEN ALLEN, Va.,
July 31, 2012 /PRNewswire/ -- Star Scientific, Inc. (NASDAQ: CIGX) is proud to congratulate Anatabloc® Brand Ambassador
Fred Couples on his victory at the 2012 Senior British Open in Turnberry, Scotland. In an exciting finish on Sunday, Couples sunk a 25-foot putt and made consecutive birdies on the last two holes to win the tournament by two strokes. Sunday's win marked the first individual victory in
Britain for the 52-year-old veteran of the PGA Tour, and his second win of 2012.
began airing its national television commercial advertising Anatabloc® and featuring
as Anatabloc® Brand Ambassador. The commercial is airing currently on the Golf Channel, and it will air on other networks this summer as well. The commercial can be viewed by clicking on the YouTube link on the Anatabloc® website at
Couples discovered Anatabloc® on his own, and within days after using it, "simply started feeling better." In
, he became Brand Ambassador for Anatabloc® and now proudly wears the Anatabloc® logo on his sleeve during competition. Couples, who has been vocal in sharing his positive experience with Anatabloc®, recently stated, "I hope my story will let millions know that Anatabloc® may be an answer in helping them return to an active lifestyle."
, Vice President of Sales and Marketing for Star Scientific, commented, "Freddie is having a wonderful season and we can't wait to see what he does next. Fred began taking Anatabloc® to manage excessive inflammation and he ultimately became our Brand Ambassador. We are extremely excited to see him playing so well."
Couples is a 32-year veteran of the PGA Tour, with over 50 professional tournament wins including the Masters (1992), and has been named twice the PGA Tour Player of the Year (1991, 1992). More recently, he was named Captain of the U.S. Team for the 2013 Presidents Cup. The 2013 Presidents Cup will be held at Muirfield Village Golf Club in
, and will be the third time Couples has served as Captain of the U.S. team. For more information about Anatabloc®, visit
Certain statements contained in this release constitute forward-looking statements within the meaning of the Private Securities Litigation Reform Act of 1995. Such statements include, but are not limited to statements identified by words such as "believes," "expects," "anticipates," "estimates," "intends," "plans," "targets," "projects" and similar expressions. The statements in this release are based upon the current beliefs and expectations of our company's management and are subject to significant risks and uncertainties. Actual results may differ from those set forth in the forward-looking statements. Numerous factors could cause or contribute to such differences, including, but not limited to, results of clinical trials, the challenges inherent in new product development initiatives, including the continued development and market acceptance of our nutraceutical and low-TSNA tobacco products, our ability to license and protect our intellectual property, our ability to raise additional capital in the future that is necessary to maintain our business, changes in government policy and/or regulation, including with respect to our nutraceutical and low-TSNA tobacco products, as well as other risks discussed from time to time in our filings with the Securities and Exchange Commission, including, without limitation, our annual report on Form 10-K for the fiscal year ended
December 31, 2011
. We undertake no duty to update any forward-looking statement or any information contained in this press release or in other public disclosures at any time.
About Star Scientific
Star Scientific, Inc. is a technology-oriented company with a mission to promote maintenance of a healthy metabolism, as well as to reduce the harm associated with the use of tobacco at every level. Over the last several years, through its wholly owned subsidiary, Rock Creek Pharmaceuticals, Star Scientific has been engaged in the manufacturing, sale, and marketing of two nutraceutical dietary supplements, and the development of other nutraceuticals and pharmaceuticals. The company also has continued to pursue the development, implementation, and licensing of the technology behind its proprietary StarCured® tobacco curing process, which substantially prevents the formation of carcinogenic toxins present in tobacco and tobacco smoke, primarily the tobacco-specific nitrosamines, or TSNAs and related low-TSNA dissolvable tobacco products. Rock Creek Pharmaceuticals has scientific and research offices in
, and a regulatory office in
, DC. Star Scientific has a Corporate and Sales Office in
Glen Allen, VA
, an Executive, Scientific & Regulatory Affairs office in
, and a manufacturing facility in
Chase City, VA
Talhia T. Tuck
Vice President, Communications and Investor RelationsStar Scientific, Inc. (301) 654-8300